COMPANY INFO
Field Medical, Inc. was founded in 2022 by Dr. Steven Mickelsen and is headquartered in Encinitas, California. The company, with about 6 employees, operates in the Surgical Devices industry and develops advanced pulsed field ablation catheters to improve cardiac ablation procedures by enhancing efficacy and minimizing unintended impacts. Their website is https://www.fieldmedicalinc.com.
Field Medical, Inc. is an innovative medical equipment manufacturing company founded in 2022 by Dr. Steven Mickelsen and headquartered in Encinitas, California. Operating in the surgical devices sector with a team of about 6 employees, Field Medical, Inc. is dedicated to advancing cardiac pulsed field ablation technology. The company develops next-generation ablation catheters designed to improve cardiac ablation procedures—enhancing efficacy while minimizing unintended impacts on surrounding tissue.
Field Medical, Inc. funding history reflects a strong focus on both product innovation and clinical validation. The company has raised a total of $75 million across two primary funding rounds. These rounds were strategically timed to support early development, pilot clinical studies, and then major growth initiatives in preparation for pivotal trials. Key milestones include the rapid conversion of early seed financing as part of their Series A, followed by a substantial Series B to fuel the development and regulatory advancement of the FieldForce™ Pulsed Field Ablation platform. The company’s funding strategy emphasizes partnership with experienced healthcare investors and a focus on clinical and operational scale-up.
This most recent Series B round, totaling $35 million and co-led by BioStar Capital and Cue Growth Partners, is dedicated to advancing the development of the FieldForce™ Pulsed Field Ablation platform, initiating the pivotal VERITAS trial, and expanding Field Medical, Inc.’s clinical and regulatory operations.
The $40 million Series A round included both new capital and the conversion of seed-round debt. This capital supported product development, the completion of pilot studies (VCAS for VT and Field PULSE for AF), and key operational scale-up activities in anticipation of the company’s pivotal clinical studies.
The seed round, totaling $20 million, was used to fund Field Medical, Inc.’s initial launch and early development. This seed investment was subsequently converted as part of the Series A, accelerating product and study milestones.
BioStar Capital is a healthcare-focused venture capital firm known for investing in transformational medical technologies. As a co-lead investor in Field Medical, Inc.’s Series B, BioStar Capital plays a critical role in supporting the company’s advancement toward pivotal clinical trials and commercialization.
Cue Growth Partners is an experienced venture capital group specializing in early-stage medtech investments. As a major backer in the Series B round, Cue Growth brings capital, strategic guidance, and deep sector expertise to Field Medical, Inc., supporting its product development, market access, and clinical programs.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Field Medical, Inc. funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.